DYNAMICS OF IRIG IN TREATMENT OF HEART TRANSPLANT REJECTIONS

In cardiac recipients non-invasive monitoring will identify the risk of acute rejection, as well as reduce the number of routine biopsies. The relation between the development of the transplanted heart rejection and the change of elastic properties of common carotid artery has been proved. Aim: to analyze dynamics of iRIG in treatment of graft rejection in heart recipients.

Materials and methods. 59 heart recipients were examined: 21 patients (pts)
without rejection, 20 pts – with rejection after 1st biopsy, 15 pts – with rejection after 1st and 2 biopsies, 3 pts – with persistent rejection after all biopsies. iRIG was estimated using empirical equation.

Results. Dynamics of iRIG in pts. without rejection according to all biopsies over time was not signifi cantly changed 6280 ± 2143, 6083 ± 2388, 6362 ± 1984 and 6188 ± 3012 cm/sec2 (p = 0.11, p = 0.13, p = 0.17 between the 1st and 2nd, 2nd and 3rd, 3rd and 4th values, respectively). In pts. with rejection iRIG decreased during treatment, but was signifi cantly higher even after successful treatment. In patients with persistent rejection iRIG did not decrease and tended to increase (17 459 ± 9702 cm/sec2 on the results of the 1st biopsy to 21 305 ± 10 448 cm/sec2 on the results of the 4th biopsy).

Conclusions. In patients with heart transplant iRIG does not change signifi cantly with the time after transplantation. iRIG increases in all types of rejection, followed by its decrease in the course of therapy; in patients with persistent rejection iRIG remains high. Evaluation of iRIG can be used for non-invasive monitoring of patients after heart transplantations (HTx) and to identify patients at high risk of transplant rejection.

1. Готье СВ, Шевченко АО, Попцов ВН. Пациент с трансплантированным сердцем: Руководство для врачей по ведению пациентов, перенесших трансплантацию сердца. М.–Тверь: Триада, 2014: 144. Gautier SV, Shevchenko AO, Poptsov VN. Patsient s transplantirovannym serdtsem: Rukovodstvo dlya vrachey po vedeniyu patsientov, perenesshikh transplantatsiyu serdtsa. M.–Tver': Triada, 2014: 144.

2. Способ ранней скрининговой диагностики гуморального отторжения трансплантированного сердца. Патент РФ № 2557699 от 29 июня 2015 г. Sposob rannej skriningovoj diagnostiki gumoralnogo ottorzheniya transplantirovannogo serdca. Рatent-RF-2557699-ot-29-iyunya-2015g.

3. Shevchenko AO, Tunyaeva IU, Nasyrova AA, Ilynsky IV, Shevchenko OP, Poptzov VN et al. Common carotid artery wall rigidity index is a marker of cardiac allograft rejection. J. Heart Lung. Transplant. 2015; 4S: S298.

4. Hammond EH, Stehlik J, Snow G. Utility of Histologic Parameters in Screening for Antibody-Mediated Rejection of Cardiac Allograft: A Study of 3170 Biopsies. J. Heart Lung. Transplant. 2005; 24: 2015–2021.

5. Book WM, Kelley L, Gravanis MB. Fulminant mixed humoral and cellular rejection in cardiac transрlant recipient: a review of the histologic fi ndings and literature. J. Heart. Lung. Transplant. 2003; 22; 5: 604–607.

6. Wood S. et al. Transient Blockade of Delta-like Notch Ligands Prevents Allograft Rejection Mediated by Cellular and Humoral Mechanisms in a Mouse Model of Heart Transplantation. The Journal of Immunology. 2015; 194; 6: 2899–2908.

7. Li G, Sanders JM, Bevard MH et al. CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury. Am. J. Pathol. 2008; 172 (4): 1141–1152.

8. Michael T, Gewaling M, Kojda G. Vasoprotection by nitric oxide, mechanіsms and therapeutic potential. Cardiovascular research. 2002; 55: 250–260.

9. Nanji SA, Hancock WW, Luo B et al. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and revents spontaneous autoimmune diabetes in the NOD mouse. Diabetes. 2006; 55 (1): 27–33.

10. Gómez-Guzmán M et al. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radical Biology and Medicine. 2012; 52; 1: 70–79.